Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
AIDS Research and Human Retroviruses|August 3, 2019
Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and AgingErin E Sundermann, Kristine M Erlandson, Caitlin N Pope, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 15, 2016
Privacy-preserving genomic testing in the clinic: a model using HIV treatmentPaul J McLaren, Jean Louis Raisaro, Manel Aouri, et al.
The Journal of Infectious Diseases|December 15, 2021
Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 YearsIsabella C Schoepf, Christian W Thorball, Bruno Ledergerber, et al.
Open Forum Infectious Diseases|September 23, 2022
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency VirusBernadette Jakeman, Alexandra U Scherrer, Katharine E A Darling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2023
Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal StudyEmma F Avery, Julia N Kleynhans, Bruno Ledergerber, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 23, 2026
Current Perspectives and Emerging Directions in Research and Practice: Highlights from the 15th Annual International Workshop on Aging and HIVJun Y Byun, Raymond Jones, Evelyn Iriarte, et al.
Open Forum Infectious Diseases|July 23, 2025
Types of Myocardial Infarction in People With HIV in SwitzerlandJulia N Kleynhans, Naomi N Cobo, Emma F Avery, et al.
The Lancet. Healthy Longevity|May 6, 2023
Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 yearsIsabella C Schoepf, Andrés Esteban-Cantos, Christian W Thorball, et al.
Pharmaceutics|August 26, 2022
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in SwitzerlandPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
HIV Medicine|March 26, 2022
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021Lene Ryom, Rosa De Miguel, Aoife Grace Cotter, et al.
Pageof 14